𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of recombinant human growth hormone treatment on insulin-like growth factor (IGF-I) levels in insulin-dependent diabetic patients

✍ Scribed by M. I. Wurzburger; G. M. Prelevic; P. H. Sönksen; M. Wheeler; L. Balint-Peric


Publisher
Springer
Year
1995
Tongue
English
Weight
401 KB
Volume
32
Category
Article
ISSN
0940-5429

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Serum levels of growth hormone-binding p
✍ G. Massa; L. Dooms; R. Bouillon; M. Vanderschueren-Lodeweyckx 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 577 KB

Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulinlike growth factor I, serum levels of the high affinity growth hormone-b

Does recombinant human insulin-like grow
✍ Dunger, D.B; Acerini, C.L. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

The structure of IGF-I is similar to that of insulin, having 43 % sequence homology with human proinsulin. Both peptides can induce metabolic and mitogenic effects through their own specific receptors, which also share many structural and functional similarities. Primarily involved in the regulation

Recombinant insulin-like growth factor b
✍ José A. Figueroa; Jivesh Sharma; James G. Jackson; Martin J. McDermott; Susan G. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 942 KB

## Abstract The insulin‐like growth factors (IGFs) are potent mitogens for breast cancer cells and their activity is modulated by high affinity binding proteins (IGFBPs). We have recently shown that IGFBP‐1 purified from human amniotic fluid neutralizes IGF‐I‐dependent growth of MCF‐7 cells. In thi